PAR 11.3% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-152

  1. 3,023 Posts.
    lightbulb Created with Sketch. 1849
    Everyone needs to understand that PAR is not 100% assured and while it looks good there is still a chance that it may not pass phase 3. We need to be careful not to bet the farm or more than we are willing to lose.

    It’s certainly risk versus reward but greed and over confidence often plays a big part in these types of investments and nothing is a done deal in the sharemarket until it is. I get the impression that many see this investment as a “guarantee” and while it has amazing prospects and I am excited about it as much as most we need to just keep some perspective. (of course everyone’s situations are unique and everyone has different investment profiles and timeframes etc)

    Simply ask yourself, if this failed phase 3 and didn’t work out how would it effect me? Would it be a scratch, a scrape, a cut, a gash, a wound requiring stitches, an amputation or in fact a mortal wound when it comes to your finances. (Instead of asking ourselves this we tend to calculate how much we will make when it hits a certain SP target. It’s just a natural bias most tend to have)

    DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
-0.030(11.3%)
Mkt cap ! $84.05M
Open High Low Value Volume
26.5¢ 26.5¢ 23.0¢ $321.5K 1.315M

Buyers (Bids)

No. Vol. Price($)
9 281527 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 48409 6
View Market Depth
Last trade - 13.13pm 21/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.